WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morikawa, E.
Right arrow Articles by Kirino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morikawa, E.
Right arrow Articles by Kirino, T.

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 1, 1998, 18(23):9727-9732

Attenuation of Focal Ischemic Brain Injury in Mice Deficient in the epsilon 1 (NR2A) Subunit of NMDA Receptor

Eiharu Morikawa1, 3, 4, Hisashi Mori2, Yuji Kiyama2, Masayoshi Mishina2, 4, Takao Asano3, and Takaaki Kirino1, 4

Departments of 1 Neurosurgery and 2 Molecular Neurobiology and Pharmacology, University of Tokyo Faculty of Medicine, Bunkyo-ku, Tokyo 113-8655, Japan, 3 Department of Neurosurgery, Saitama Medical School/Center, Kawagoe, Saitama 350-8550, Japan, and 4 Core Research for Evolution and Technology, Japan Science and Technology Corporation, Kawaguchi, 332-0012, Japan

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The role of glutamate neurotoxicity in cerebral ischemia has long been advocated but still remains controversial, because various glutamate receptor (GluR) antagonists showed inconsistent protective efficacy in brain ischemia models. To address this central issue of ischemic brain damage more directly, we used mutant mice deficient in the GluRepsilon 1 (NR2A) subunit of NMDA receptor with or without additional heterozygous mutation in the GluRepsilon 2 (NR2B) subunit. Those mutant mice, as well as their littermates, were subjected to focal cerebral ischemia by introducing a 6-0 nylon suture from left common carotid artery. Brain injury volumes after 2 hr of suture insertion, as evaluated by 2,3,5-triphenyltetrazolium chloride staining at 24 hr after ischemia, revealed significantly smaller injury size in GluRepsilon 1 subunit knock-out mice compared with their wild-type littermates. The reduction in injury volume was not attributable to differences in body temperature or in blood flow during ischemia. Additional heterozygous GluRepsilon 2 subunit disruption did not result in further reduction in injury volume. These data directly demonstrate relevance of NMDA receptor-mediated tissue injury after brain ischemia and provide evidence that GluRepsilon 1 subunit is involved in these injurious mechanisms.

Key words: NMDA receptor; GluRepsilon 1 subunit; neurotoxicity; glutamate; brain ischemia; cerebral infarction

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Brain ischemia causes massive elevation of extracellular glutamate concentration. An excess amount of glutamate is postulated to induce glutamate receptor (GluR)-mediated cascade reactions, which eventually lead to brain damage (Choi, 1988; Lipton and Rosenberg, 1994). Molecular cloning studies have identified five NMDA receptor subunits called GluRzeta 1 (NR1) and GluRepsilon 1-GluRepsilon 4 (NR2A-NR2D) (Nakanishi, 1992; Seeburg, 1993, Mori and Mishina, 1995). Among these five subunits, GluRzeta 1, GluRepsilon 1 (NR2A), and GluRepsilon 2 (NR2B) are the major components of the hetero-oligomeric NMDA receptor channel complex distributed in the mature forebrain (Watanabe et al., 1992). The GluRzeta 1 and GluRepsilon 2 subunits are the constituents of the receptor molecule during stages of embryonic development. Mice with a null mutation in the GluRzeta 1 or the GluRepsilon 2 subunit gene die shortly after birth and have a defect in the formation of neuronal pattern in the brainstem (Forrest et al., 1994; Li et al., 1994; Kutsuwada et al., 1996). In contrast, GluRepsilon 1 subunit is expressed only in the postnatal brain, and mice lacking the gene for this subunit (epsilon 1-/-) develop and mate normally. Detailed electrophysiological and behavioral evaluation, however, has revealed that the GluRepsilon 1 subunit knock-out (epsilon 1KO) mice have reduced hippocampal long-term potentiation (LTP) and impaired spatial and contextual learning, which confirms that disruption of this gene disturbs normal NMDA receptor functions (Sakimura et al., 1995; Kiyama et al., 1998). We subjected these mice to focal cerebral ischemia to investigate the significance of the GluRepsilon 1 subunit of NMDA receptor in the development of tissue injury after brain ischemia. Furthermore, we mated these epsilon 1KO mice with other genetically engineered mice harboring a heterozygous GluRepsilon 2 mutation (epsilon 1+/+epsilon 2+/-, Kutsuwada et al., 1996) to create mice with both a null mutation in the GluRepsilon 1 gene and a heterozygous mutation in the GluRepsilon 2 gene (epsilon 1-/-epsilon 2+/-, epsilon 1KOepsilon 2H). To study the significance of the remaining GluRepsilon 2 subunit in epsilon 1KO mice, we also evaluated the development of ischemic brain injury in these double-mutant mice.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Production of mice with GluRepsilon 1 and/or GluRepsilon 2 subunit gene mutation. Generation and characterization of the GluRepsilon 1 subunit knock-out (Sakimura et al., 1995) and GluRepsilon 2 subunit knock-out (Kutsuwada et al., 1996) in TT2 embryonic stem cells, followed by back-crossing with C57BL/6 mice, have been described elsewhere. Mice with GluRepsilon 1 homozygous and GluRepsilon 2 heterozygous mutation were produced by mating the homozygous GluRepsilon 1 mutant mice (epsilon 1-/-epsilon 2+/+) with GluRepsilon 2 heterozygous mutant mice (epsilon 1+/+epsilon 2+/-). The resultant heterozygous mutants for both GluRepsilon 1 and GluRepsilon 2 (epsilon 1+/-epsilon 2+/-) were crossed with GluRepsilon 1 homozygous mutants (epsilon 1-/-epsilon 2+/+) to generate GluRepsilon 1 homozygous and GluRepsilon 2 heterozygous mutant mice (epsilon 1-/-epsilon 2+/-). The offspring mice (epsilon 1-/-epsilon 2+/-) were mated again with GluRepsilon 1 homozygous mutants (epsilon 1-/-epsilon 2+/+) to expand the colony of GluRepsilon 1 homozygous and GluRepsilon 2 heterozygous mutant mice (epsilon 1-/-epsilon 2+/-) and homozygous mutant mice for GluRepsilon 1 (epsilon 1-/-epsilon 2+/+).

Western blot analysis of GluRepsilon 1 and GluRepsilon 2 subunit proteins in the forebrain. Western blot analysis was done essentially as described previously (Sakimura et al., 1995; Takahashi et al., 1996; Watanabe et al., 1998). In brief, the wild-type (WT) and mutant mice were decapitated under anethesia, and each forebrain was removed rapidly and homogenized. The proteins (100 mg) prepared from each forebrain homogenate were fractionated by SDS-PAGE and electroblotted onto a nitrocellulose membrane. The blots were immunoreacted with anti-GluRepsilon 1, anti-GluRepsilon 2, or anti-neuron-specific enolase (NSE) antibody, and the protein bands were visualized by chemiluminescence (ECL detection system; Amersham, Arlington Heights, IL). The rabbit anti-GluRepsilon 1, anti-GluRepsilon 2, and anti-NSE antibodies were prepared previously (Sakimura et al., 1980, 1995; Watanabe et al., 1998). For quantitative analysis, the immunoreactive bands were scanned using a computing densitometry and analyzed with NIH Image software (version 1.58). The quantity of the immunoreactive bands of GluRepsilon 1 and GluRepsilon 2 proteins were corrected by comparing them with the band of NSE protein as an internal standard for the amount of protein loaded onto the gels.

Production of focal cerebral ischemia. Nonfasted mice of either sex were subjected to cerebral ischemia by an investigator (E.M.) blinded to the group identity. Anesthesia was induced and maintained by halothane (3 and 1%, respectively) plus 50% nitrous oxide and the balance of oxygen under spontaneous ventilation. Because repeated blood withdrawal from mice was not compatible with further ischemia experiments, the samples for physiological data (arterial pO2, pCO2, pH, and blood glucose) were taken from a separate set of animals (n = 5 each). These physiological parameters were maintained within normal range under the setting of ischemia induction, and there were no differences between the groups. Focal cerebral ischemia was produced as described previously (Huang et al., 1994). After ligation of the left proximal common carotid artery, a 6-0 nylon monofilament (Ethilon; Ethicon, Inc., Somerville, NJ) with a heat-modified head was introduced into the distal internal carotid artery and was advanced ~11 mm distal to the carotid bifurcation. The filament was wedged into the circle of Willis, producing focal cerebral ischemia in the left middle cerebral artery territory. The wound was closed, and the animal was returned to its cage. In transient focal cerebral ischemia, the nylon filament was withdrawn from the carotid artery 2 hr after insertion under halothane anesthesia. During the surgical procedure, the rectal temperature was kept normothermic (36.5-37.5°C) by a heating pad and a heating lamp (ATB-1100; Nihon Koden, Tokyo, Japan).

Evaluation of tissue injury after ischemia. Twenty-four hours after arterial occlusion, the mice were anesthetized with 3% halothane and decapitated. Brains were removed immediately and placed in ice-cold saline for 10 min and sectioned coronally into 5 slices (2-mm-thick) in a rodent brain matrix (Mouse Brain Slicer; Medical Agent Co. Ltd., Tokyo, Japan). Brain slices were placed in 2% 2,3,5-triphenyltetrazolium chloride monohydrate (TTC) (Sigma, St. Louis, MO) at room temperature for 30 min (Bederson et al., 1986), followed by 10% formalin overnight. Brain slices were directly scanned on an image scanner (JX-320M; Sharp, Tokyo, Japan). The area of ischemic injury was measured (NIH Image software) on the posterior surface of each section. The injury volume was calculated by numeric integration of the sequential areas. Eight mice could not survive for 24 hr after ischemia. Because exclusion of these mice could affect overall effects of the gene mutation on the ischemic injury, the brains of those animals were removed as soon as the animal's death was confirmed, and the size of the brain injury was evaluated by the same method as above.

Genotyping of mice by Southern blot hybridization analysis. Genotyping of the mice that were used for the brain injury analysis was done in a completely blind manner by another investigator (H.M.). Genotype of each mouse was identified by Southern blot hybridization analysis of the genomic DNA extracted from tail specimen taken at the time of death as described above. In brief, Southern blot hybridization analysis of the GluRepsilon 1 locus was done using BamHI-digested tail DNA hybridized with a 1.2 kb SmaI-SmaI fragment of the GluRepsilon 1 gene (Sakimura et al., 1995). Southern blot hybridization analysis of the GluRepsilon 2 locus was performed using EcoRI-digested tail DNA hybridized with a 0.4 kb HindIII-XbaI fragment of the GluRepsilon 2 gene (Kutsuwada et al., 1996).

Evaluation of regional cerebral blood flow by laser-Doppler flowmetry. Under halothane anesthesia with spontaneous ventilation as described above, regional cerebral blood flow (CBF) at dorsolateral cerebral cortex was determined by laser-Doppler flowmetry (LBF-IIIF; Biomedical Science, Tokyo, Japan) as demonstrated previously (Morikawa et al., 1996). After exposing and thinning the skull at 1 mm posterior and 4 mm lateral to the bregma, the head of the mouse was fixed in a stereotaxic frame (Narishige, Tokyo, Japan) in supine position, and the tip of the flowmetry probe (0.8 mm in diameter) was secured perpendicular to the skull surface. After baseline measurements were obtained, the left common carotid artery was ligated, and the nylon suture was inserted. Regional CBF was measured for 30 min after suture insertion.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Expression of the GluRepsilon 1 and GluRepsilon 2 subunit proteins in mutant mice

We first examined the expression levels of GluRepsilon 1 and GluRepsilon 2 subunit proteins in the forebrain of the WT and mutant mice using Western blot analysis. The intensities of immunoreactive bands of GluRepsilon 1 and GluRepsilon 2 proteins were quantitatively analyzed and compared with those of NSE, a marker protein of neurons (Schmechel et al., 1978), as an internal standard. The amounts of GluRepsilon 1 and GluRepsilon 2 subunit proteins were comparable between male and female WT mice and between male and female epsilon 1KO mice, indicating that there was no appreciable gender difference in the expression of GluRepsilon 1 and GluRepsilon 2 proteins (Fig. 1A). These analyses also confirmed the absence of GluRepsilon 1 protein in epsilon 1KO and epsilon 1KOepsilon 2H mice (Fig. 1A,B). The expression of GluRepsilon 2 protein in epsilon 1KO mice was not appreciably affected by the GluRepsilon 1 gene disruption, whereas the amount of GluRepsilon 2 protein in epsilon 1KOepsilon 2H mice was decreased to approximately half of that in WT littermates as reported previously (Fig. 1B) (Sakimura et al., 1995; Kutsuwada et al., 1996).


View larger version (29K):
[in this window]
[in a new window]
 
Figure 1.   A, Western blot analysis of forebrain proteins from WT and epsilon 1KO mice with anti-GluRepsilon 1 (top), anti-GluRepsilon 2 (middle), and anti-NSE (bottom) antibodies. Samples from two males (M) and two females (F) of each genotype were presented. B, Western blot analysis of forebrain proteins from WT, epsilon 1KO, and epsilon 1KOepsilon 2H male mice with anti-GluRepsilon 1 (top) and anti-GluRepsilon 2 antibodies (bottom).

Brain injury volumes after ischemia

A total of 105 mice were subjected to focal cerebral ischemia by occluding the left middle cerebral artery using nylon filament. The brain injury volume after permanent focal cerebral ischemia was not significantly different between epsilon 1KO and WT mice [91 ± 14 (n = 13) and 108 ± 8 (n = 14) mm3, respectively]. Although there was a trend toward smaller injury volumes in female epsilon 1KO mice, there was not a statistically significant difference between males and females (Fig. 2). Two male WT mice died at 19.5 and 16.5 hr of ischemia, and their injury volumes were 149 and 141 mm3, respectively. There was not a premature mortality in epsilon 1KO mice.


View larger version (40K):
[in this window]
[in a new window]
 
Figure 2.   Cerebral injury volumes after permanent focal cerebral ischemia. There were no statistically significant differences in injury volumes between WT and epsilon 1KO mice in either males (n = 8 and 4 for WT and epsilon 1KO, respectively) or females (n = 6 and 9 for WT and epsilon 1KO, respectively). Values are expressed as mean ± SEM.

After 2 hr of transient focal ischemia, epsilon 1KO mice developed significantly smaller brain injury volumes compared with WT mice [41 ± 7 (n = 19) and 87 ± 8 (n = 28) mm3 for epsilon 1KO and WT, respectively; p = 0.0004; unpaired t test]. When the data were analyzed separately with regard to gender, the difference was more prominent in females [30 ± 9 (n = 7) and 94 ± 12 (n = 14) mm3, respectively; p = 0.0039; unpaired t test] than in males [48 ± 10 (n = 12) and 80 ± 10 (n = 14) mm3, respectively; p = 0.044; unpaired t test] (Fig. 3). There was, however, no statistically significant difference in injury volumes between males and female in either WT or epsilon 1KO mice. Five WT mice (one male and four females) died between 18 and 22 hr of ischemia and had large injury volumes (between 135 and 187 mm3). On the other hand, there was no premature mortality in epsilon 1KO mice. The difference in mortality rate reached statistical significance when the data of the above two studies were combined (p < 0.05; chi 2 test).


View larger version (24K):
[in this window]
[in a new window]
 
Figure 3.   Cerebral injury volumes after 2 hr of transient focal cerebral ischemia. epsilon 1KO mice had significantly smaller injury volume compared with WT littermate mice in both males (n = 14 and 12 for WT and epsilon 1KO, respectively; *p = 0.044) and females (n = 14 and 7 for WT and epsilon 1KO, respectively; **p = 0.0039). Values are expressed as mean ± SEM.

The injury volume in epsilon 1KOepsilon 2H mice after 2 hr of transient focal ischemia was similar to those of epsilon 1KO mice, and there was no additional reduction of injury volume by further disrupting one copy of the GluRepsilon 2 subunit gene [34 ± 8 (n = 17) and 43 ± 9 (n = 14) mm3 for epsilon 1KOepsilon 2H and epsilon 1KO, respectively] (Fig. 4). One male epsilon 1KOepsilon 2H mouse died at 22 hr of ischemia and had an injury volume of 28 mm3. There was no premature mortality in epsilon 1KO mice.


View larger version (24K):
[in this window]
[in a new window]
 
Figure 4.   Cerebral injury volumes after 2 hr of transient focal cerebral ischemia compared with epsilon 1KOepsilon 2H mice and their littermates epsilon 1KO. There were no significant differences between these two groups in either males (n = 6 each) or females (n = 8 and 11 for epsilon 1KO and epsilon 1KOepsilon 2H, respectively). Values are expressed as mean ± SEM.

When the injury size was examined in 2-mm-thick consecutive slices, the reduction of ischemic injury in mutant mice compared with WT mice was evident in all five slices (p < 0.01; one-way ANOVA, followed by Fisher's PLSD test) (Fig. 5A). Notably, the attenuation of injury was more evident in the dorsolateral cerebral cortex, which is the area of milder ischemia called "ischemic penumbra" (Fig. 5B,C).


View larger version (56K):
[in this window]
[in a new window]
 
Figure 5.   A, Areas of cerebral injury on each brain slice after 2 hr of transient focal cerebral ischemia. Data from two experiments are combined [epsilon 1KO (n = 33), epsilon 1KOepsilon 2H (n = 17), and WT (n = 28)]. Reduction of injury area was observed on all the brain slices in epsilon 1KO and epsilon 1KOepsilon 2H mice compared with WT (p < 0.01; one-way ANOVA, followed by Fisher's PLSD test). Values are expressed as mean ± SEM. B, Spatial distribution of injury areas on five brain slices. Black areas indicate regions of brain injury observed in most of the animals (>70%) in the group. Dark gray and light gray areas demonstrate regions of injury observed less frequently (40-70 and 20-40%, respectively). C, Representative scanned images of TTC-stained brain slices analyzed for injury volume. White areas indicate regions of tissue injury. Calculated injury volumes for these particular animals were 100, 39, and 35 mm3 for WT, epsilon 1KO, and epsilon 1KOepsilon 2H, respectively.

Regional CBF after brain ischemia

To exclude the possibility that gene disruptions could cause different CBF after middle cerebral artery occlusion, which could influence the results, we measured regional CBF before and after the occlusion in a separate set of animals (n = 5 in each group). Regional CBF at dorsolateral cerebral cortex, as measured continuously by laser-Doppler flowmetry, demonstrated reduction of CBF by ~35% when common carotid artery was occluded. The CBF further decreased to ~17% of baseline after insertion of the nylon suture, which recovered and remained at a level of ~22% of baseline during the first 30 min without any significant difference between the two groups (Fig. 6). Thus, the reduction in ischemic injury volumes was not attributable to the regional CBF differences in the dorsolateral cerebral cortex, or ischemic penumbra, in the acute stage.


View larger version (17K):
[in this window]
[in a new window]
 
Figure 6.   Regional CBF profiles measured at dorsolateral cerebral cortex using laser-Doppler flowmetry after vessel occlusion in WT (n = 5) and epsilon 1KO (n = 5) mice. Values are expressed as mean ± SEM. Regional CBF was reduced by ~35% of baseline after common carotid artery occlusion. Insertion of the nylon suture resulted in further reduction of the CBF to ~20% of baseline for 30 min. No significant differences were detected in CBF between epsilon 1KO and WT mice.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The present investigation clearly demonstrates for the first time that mice lacking the GluRepsilon 1 subunit of NMDA receptor channel are less prone to cerebral injury after focal brain ischemia. Functional NMDA receptor channel complexes contain both GluRzeta and GluRepsilon subunits. In the forebrain of mature mice, GluRepsilon constituents making up the hetero-oligomeric receptors are primarily the GluRepsilon 1 and GluRepsilon 2 subunits (Watanabe et al., 1992). Western blot analyses in this study confirmed that the targeted disruption of the GluRepsilon 1 subunit gene resulted in complete absence of GluRepsilon 1 subunit protein in the brain homogenate and that there was no compensatory increase in the content of GluRepsilon 2 subunit protein. In fact, the NMDA receptor channel activity in the hippocampal CA1 region of epsilon 1KO mice is decreased to about half of that of WT mice, and correspondingly, thresholds for hippocampal LTP induction and contextual learning are increased (Sakimura et al., 1995; Kiyama et al., 1998). Thus, a straightforward explanation of our results will be that the decrease in the number of functional NMDA receptor channels on the cell membrane of forebrain neurons in epsilon 1KO mice has made cells more resistant to glutamate-induced neurotoxicity. Consistent with this, it was reported that the suppression of GluRzeta 1 subunit synthesis by administrating antisense oligodeoxynucleotides reduced infarction volumes produced by focal brain ischemia (Wahlestedt et al., 1993).

This explanation implies that the another constituent of NMDA receptor channels, the GluRepsilon 2 subunit, would also be involved in glutamate-induced neurotoxicity. In agreement with this, it is demonstrated that selective GluRepsilon 2 subunit antagonist provides brain protection in feline brain ischemia (Di et al., 1997). In our study, however, further disruption of one copy of the GluRepsilon 2 subunit gene in epsilon 1KO mice (epsilon 1KOepsilon 2H mice) appeared to have no additional protective effects against ischemia. It is possible that the extent of reduction in GluRepsilon 2 subunit protein may not be significant enough to bring additional protective effects already bestowed by complete deletion of the GluRepsilon 1 gene.

Alternatively, the GluRepsilon 1 subunit may indeed play a more pivotal role in glutamate neurotoxicity than the GluRepsilon 2 subunit. Interestingly, in this regard, it is demonstrated that vulnerability of CA1 neurons to glutamate is intrinsically less in newborns and more in 3-week-old rats, suggesting that the expression of the GluRepsilon 1 subunit, whose expression occurs postnatally, increases the glutamate neurotoxicity (Marks et al., 1996).

Differences in gating and pharmacological properties, as well as in various modulations, are noted between GluRepsilon 1/zeta 1 and GluRepsilon 2/zeta 1 channels (Seeburg, 1993; Mori and Mishina, 1995). Calcium-dependent inactivation of NMDA receptor channels, observed in the cultured hippocampal neurons (Legendre et al., 1993), is shown to be subunit-specific, requires the presence of the GluRepsilon 1 subunit, and is less pronounced in GluRepsilon 2 subunit-containing heteromers (Krupp et al., 1996). The offset decay time constant of the GluRepsilon 1/zeta 1 channel is ~120 msec and that of the GluRepsilon 2/zeta 1 channel is ~400 msec (Monyer et al., 1994). The duration of NMDA receptor channel-mediated EPSCs in neurons of the visual cortex layer IV and superior colliculus is longer at early developmental stages and becomes progressively shorter (Hestrin, 1992; Carmignoto and Vicini, 1992). Neurons of postnatal neocortex expressing the GluRepsilon 1 subunit have faster EPSCs, and the proportion of cells expressing this subunit increases developmentally (Flint et al., 1997). The absence of the GluRepsilon 1 subunit, therefore, would lead to qualitative changes of NMDA receptor channel functions in the brain. In fact, alterations in NMDA receptor channel properties have been demonstrated in epsilon 1KO mice. In cerebellar granule cells, the decay time course of NMDA receptor-mediated EPSCs was slower in the mutants compared with WT (Takahashi et al., 1996). In hippocampal CA3 pyramidal neurons, reduction in the NMDA receptor-mediated EPSCs was observed selectively at the synapses formed by commissural-associational inputs (Ito et al., 1997). These differences between GluRepsilon 1 and GluRepsilon 2 heteromers in receptor channel functions, however, do not necessarily support the hypothesis that the GluRepsilon 1 subunit is more involved in neurotoxicity than the GluRepsilon 2 subunit.

Although glutamate neurotoxicity has been implicated as a major mechanism of ischemic brain injury (Choi, 1988; Lipton and Rosenberg, 1994), the effects of antagonists directed against NMDA receptors have been unsatisfactory in clinical trials (Lipton, 1993; Schehr, 1996), as well as in experimental animals (Buchan and Pulsinelli, 1990). In the current study, significant reduction in injury volume was observed in the GluRepsilon 1 subunit-deficient mice in transient brain ischemia but not in permanent ischemia in which only a trend toward smaller injury volume was observed in females. It is also noted that the attenuation of tissue injury was predominantly in the so-called ischemic penumbra and was less in the core region. Thus, the resistance provided by the GluRepsilon 1 subunit ablation was prominent in mild to moderate ischemia but less so in severe ischemic insult. This is in accordance with the notion that mechanisms other than the NMDA receptor-mediated type may become dominant in severe brain ischemia (Siesjo, 1992). It is hypothesized that brain ischemia induces downregulation of the GluR2 subunit of AMPA receptors, which renders AMPA receptor channels permeable to calcium and, consequently, increases glutamate-induced neurotoxicity after ischemia (Pellegrini-Giampietro et al., 1992; Gorter et al., 1997). Our results, however, indicate significant involvement of the NMDA receptor channel-mediated neurotoxicity in focal cerebral ischemia and reperfusion.

Although it has been demonstrated that estrogens attenuate excitotoxic injury (Goodman et al., 1996) and also upregulate NMDA receptors (Woolley et al., 1997), which may exacerbate glutamate-induced neurotoxicity, statistically significant gender difference was not observed in the current study in terms of ischemic injury. There was not a significant gender difference in the amounts of GluRepsilon 1 and GluRepsilon 2 subunit proteins in brain homogenate taken from WT or epsilon 1KO mice, either. In any case, our data demonstrate direct evidence that NMDA receptor channels, specifically the GluRepsilon 1 subunit, play a major role in ischemic brain injury in both males and females.

    FOOTNOTES

Received May 7, 1998; revised Sept. 21, 1998; accepted Sept. 22, 1998.

This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan. We thank Dr. Keisuke Ueki for helpful comments and advice and Dr. Nobuto Saito for technical assistance.

Correspondence should be addressed to Dr. Takaaki Kirino, Department of Neurosurgery, University of Tokyo Faculty of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  • Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308[Abstract/Free Full Text].
  • Buchan A, Pulsinelli WA (1990) Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 10:311-316[Abstract].
  • Carmignoto G, Vicini S (1992) Activity-dependent decrease in NMDA receptor responses during development of the visual cortex. Science 258:1007-1011[Abstract/Free Full Text].
  • Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634[Web of Science][Medline].
  • Di X, Bullock R, Watson J, Fatouros P, Chenard B, White F, Corwin F (1997) Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage and cytotoxic brain edema after middle cerebral artery occlusion in the feline brain. Stroke 28:2244-2251[Abstract/Free Full Text].
  • Flint AC, Maisch US, Weishaupt JH, Kriegstein AR, Monyer H (1997) NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J Neurosci 17:2469-2476[Abstract/Free Full Text].
  • Forrest D, Yuzaki M, Soares HD, Ng L, Luk DC, Sheng M, Stewart CL, Morgan JI, Connor JA, Curran T (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13:325-338[Web of Science][Medline].
  • Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844[Web of Science][Medline].
  • Gorter JA, Petrozzino JJ, Aronica EM, Rosenbaum DM, Opitz T, Bennett MVL, Connor JA, Zukin RS (1997) Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 17:6179-6188[Abstract/Free Full Text].
  • Hestrin S (1992) Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature 357:686-689[Medline].
  • Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883-1885[Abstract/Free Full Text].
  • Ito I, Futai K, Katagiri H, Watanabe M, Sakimura K, Mishina M, Sugiyama H (1997) Synapse-selective impairment of NMDA receptor functions in mice lacking NMDA receptor epsilon 1 or epsilon 2 subunit. J Physiol (Lond) 500:401-408[Abstract/Free Full Text].
  • Kiyama Y, Manabe T, Sakimura K, Kawakami F, Mori H, Mishina M (1998) Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor epsilon 1 subunit. J Neurosci 18:6704-6712[Abstract/Free Full Text].
  • Krupp JJ, Vissel B, Heinemann SF, Westbrook GL (1996) Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific. Mol Pharmacol 50:1680-1688[Abstract].
  • Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, Watanabe M, Inoue Y, Yagi T, Aizawa S, Arakawa M, Takahashi T, Nakamura Y, Mori H, Mishina M (1996) Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16:333-344[Web of Science][Medline].
  • Legendre P, Rosenmund C, Westbrook GL (1993) Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium. J Neurosci 13:674-684[Abstract].
  • Li Y, Erzurumlu RS, Chen C, Jhaveri S, Tonegawa S (1994) Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76:427-437[Web of Science][Medline].
  • Lipton SA (1993) Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox state of nitric oxide. Trends Neurosci 16:527-532[Web of Science][Medline].
  • Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622[Free Full Text].
  • Marks JD, Friedman JE, Haddad GG (1996) Vulnerability of CA1 neurons to glutamate is developmentally regulated. Brain Res Dev Brain Res 97:194-206[Medline].
  • Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540[Web of Science][Medline].
  • Mori H, Mishina M (1995) Structure and function of the NMDA receptor channel. Neuropharmacology 34:1219-1237[Web of Science][Medline].
  • Morikawa E, Zhang S-M, Seko Y, Toyoda T, Kirino T (1996) Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin. Stroke 27:951-956[Abstract/Free Full Text].
  • Nakanishi S (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603[Abstract/Free Full Text].
  • Pellegrini-Giampietro DE, Zukin RS, Bennet MVL, Cho S, Pulsinelli WA (1992) Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci USA 89:10499-10503[Abstract/Free Full Text].
  • Sakimura K, Yoshida Y, Nabeshima Y, Takahashi Y (1980) Biosynthesis of the brain-specific 14-3-2 protein in a cell-free system from wheat germ extract directed with poly(A)-containing RNA from rat brain. J Neurochem 34:687-693[Web of Science][Medline].
  • Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, Mishina M (1995) Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 373:151-155[Medline].
  • Schehr RS (1996) New treatments for acute stroke. Nat Biotechnol 14:1549-1554[Web of Science][Medline].
  • Schmechel D, Marangos PJ, Zis AP, Brightman M, Goodwin FK (1978) Brain enolases as specific markers of neuronal and glial cells. Science 199:313-315[Abstract/Free Full Text].
  • Seeburg PH (1993) The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 16:359-365[Web of Science][Medline].
  • Siejo BK (1992) Pathophysiology and treatment of focal cerebral ischemia. Part II: mechanisms of damage and treatment. J Neurosurg 77:337-354[Web of Science][Medline].
  • Takahashi T, Feldmeyer D, Suzuki N, Onodera K, Cull-Candy SG, Sakimura K, Mishina M (1996) Functional correlation of NMDA receptor epsilon  subunits expression with the properties of single-channel and synaptic currents in the developing cerebellum. J Neurosci 16:4376-4382[Abstract/Free Full Text].
  • Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ (1993) Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363:260-263[Medline].
  • Watanabe M, Inoue Y, Sakimura K, Mishina M (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs. NeuroReport 3:1138-1140[Web of Science][Medline].
  • Watanabe M, Fukaya M, Sakimura K, Manabe T, Mishina M, Inoue Y (1998) Selective scarcity of NMDA receptor channel subunits in the stratum lucidum (mossy fiber-recipient layer) of the hippocampal CA3 subfield. Eur J Neurosci 10:478-487[Web of Science][Medline].
  • Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA (1997) Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17:1848-1859[Abstract/Free Full Text].


Copyright © 1998 Society for Neuroscience  0270-6474/98/18239727-06$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. K. Graham, M. A. Pouladi, P. Joshi, G. Lu, Y. Deng, N.-P. Wu, B. E. Figueroa, M. Metzler, V. M. Andre, E. J. Slow, et al.
Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease
J. Neurosci., February 18, 2009; 29(7): 2193 - 2204.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. C. Ewald, K. R. Van Keuren-Jensen, C. D. Aizenman, and H. T. Cline
Roles of NR2A and NR2B in the Development of Dendritic Arbor Morphology In Vivo
J. Neurosci., January 23, 2008; 28(4): 850 - 861.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Chen, S. He, X.-L. Hu, J. Yu, Y. Zhou, J. Zheng, S. Zhang, C. Zhang, W.-H. Duan, and Z.-Q. Xiong
Differential Roles of NR2A- and NR2B-Containing NMDA Receptors in Activity-Dependent Brain-Derived Neurotrophic Factor Gene Regulation and Limbic Epileptogenesis
J. Neurosci., January 17, 2007; 27(3): 542 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. D. Sinor, S. Du, S. Venneti, R. C. Blitzblau, D. N. Leszkiewicz, P. A. Rosenberg, and E. Aizenman
NMDA and Glutamate Evoke Excitotoxicity at Distinct Cellular Locations in Rat Cortical Neurons In Vitro
J. Neurosci., December 1, 2000; 20(23): 8831 - 8837.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. E. McGowan, G. Sysyn, K. H. Petersson, G. B. Sadowska, O. P. Mishra, M. Delivoria-Papadopoulos, and B. S. Stonestreet
Effect of Dexamethasone Treatment on Maturational Changes in the NMDA Receptor in Sheep Brain
J. Neurosci., October 1, 2000; 20(19): 7424 - 7429.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. M. O'Dell, R. Raghupathi, P. B. Crino, J. H. Eberwine, and T. K. McIntosh
Traumatic Brain Injury Alters the Molecular Fingerprint of TUNEL-Positive Cortical Neurons In Vivo: A Single-Cell Analysis
J. Neurosci., July 1, 2000; 20(13): 4821 - 4828.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. D. Ginsberg
On Ischemic Brain Injury in Genetically Altered Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2581 - 2583.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Lipton
Ischemic Cell Death in Brain Neurons
Physiol Rev, October 1, 1999; 79(4): 1431 - 1568.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
S. I. Savitz and D. M. Rosenbaum
Review : Gene Expression after Cerebral Ischemia
Neuroscientist, July 1, 1999; 5(4): 238 - 253.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morikawa, E.
Right arrow Articles by Kirino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morikawa, E.
Right arrow Articles by Kirino, T.

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-